Schedule 13D ownership disclosure
FIVE PRIME THERAPEUTICS INC
Security class unavailable · CUSIP: 33830X104
Event date: 2021-03-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-035856
- Form type
- SC 13D
- Filer
- FIVE PRIME THERAPEUTICS, INC.
- CIK
- CIK 1175505
- Filed
- Mar 15, 2021
- Reporting period
- Mar 08, 2021
- Description
- Schedule 13D beneficial ownership